Advanced search
Publication Cover
Climacteric Volume 4, 2001 - Issue 4
Submit an article Journal homepage
34
Views
12
CrossRef citations to date
0
Altmetric
(RG) Obstetrics and Gynaecology

Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study

T. Nickelsen Eli Lilly and Company, Bad Homburg, Germany
,
G. Creatsas 2nd Department of Obstetrics and Gynecology, University of Athens, Greece
,
T. Rechberger Department of Gynecology, University of Lublin, Poland
,
H. Depypere Department of Gynecology, Universitair Ziekenhuis, Gent, Belgium
,
M. Erenus Department of Gynecology, Marmara University, Istanbul, Turkey
,
D. Quail Lilly Research Centre, Windlesham, Surrey, UK
,
T. Arndt Bioscientia Laboratories, Ingelheim, Germany
&
J. Bonnar Department of Gynecology, St James's Hospital, Dublin, Ireland
 show all
Pages 320-331 | Published online: 03 Jul 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

G. E. Christodoulakos, I. V. Lambrinoudaki, M. G. Creatsa, E. V. Economou, Z. Siasou, C. P. Panoulis, I. Kalligerou & C. Papadias. (2008) Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women. Climacteric 11:2, pages 155-165.
Read now
GE Christodoulakos, IV Lambrinoudaki, CP Panoulis, CA Papadias, EE Kouskouni & GC Creatsas. (2004) Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women. Gynecological Endocrinology 18:5, pages 244-257.
Read now
C Piperi, C Kalofoutis, A Papapanagiotou, C Skenderi & A Kalofoutis. (2004) Comparative analysis of oestrogen and raloxifene effects on the phospholipid composition of high density lipoproteins in healthy postmenopausal women. Journal of Obstetrics and Gynaecology 24:1, pages 52-57.
Read now
S. M. O'Neill, J. Eden, R. Baber, A. Ekangaki, J. M. Stocks, T. Wolthers & S. R. Davis. (2003) Transition to raloxifene with and without low-dose estrogen therapy in postmenopausal women: effects on serum lipids and fibrinogen - a pilot study. Climacteric 6:4, pages 347-353.
Read now

Articles from other publishers (8)

Alberto Salvo & Cristian Huse. (2011) Is Arbitrage Tying the Price of Ethanol to that of Gasoline? Evidence from the Uptake of Flexible-Fuel Technology. The Energy Journal 32:3.
Crossref
Wendy Shelly, Michael W. Draper, Venkatesh Krishnan, Mayme Wong & Robert B. Jaffe. (2008) Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings. Obstetrical & Gynecological Survey 63:3, pages 163-181.
Crossref
Anette Løken Eilertsen, Leiv Sandvik, Marie Christine Mowinckel, Trine Opstad Andersen, Erik Qvigstad & Per Morten Sandset. (2007) Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis. Thrombosis Research 120:3, pages 371-379.
Crossref
Chad L DealMichael W Draper. (2016) Raloxifene: A Selective Estrogen-Receptor Modulator for Postmenopausal Osteoporosis – a Clinical Update on Efficacy and Safety. Women's Health 2:2, pages 199-210.
Crossref
Molly C. Carr, Robert H. Knopp, John D. Brunzell, Barbara S. Wheeler, Xiaodong Zhu, Mark Lakshmanan, Amy S. Rosen & Pamela W. Anderson. (2005) Effect of Raloxifene on Serum Triglycerides in Women With a History of Hypertriglyceridemia While on Oral Estrogen Therapy. Diabetes Care 28:7, pages 1555-1561.
Crossref
George Christodoulakos, Irene Lambrinoudaki, Constantinos Panoulis, Constantinos Papadias, Emmanuel Economou & George Creatsas. (2004) Effect of hormone therapy and raloxifene on serum VE-cadherin in postmenopausal women. Fertility and Sterility 82:3, pages 634-638.
Crossref
George E. Christodoulakos, Constantinos P. C. Panoulis, Irene V. Lambrinoudaki, Dimitrios S. Botsis, Spyros G. Dendrinos, Emanuel Economou & George C. Creatsas. (2004) The effect of hormone therapy and raloxifene on serum matrix metalloproteinase-2 and -9 in postmenopausal women. Menopause 11:3, pages 299-305.
Crossref
Patrick Neven, Deborah Quail, Marc L?vrier, Fernanda Aguas, Hok Sien Th?Christian De Geyter, Michael D. Glant, Heike Beck, Brigitte Bosio-LeGoux, Henri Schmitt, Antje Hottgenroth & Thomas Nickelsen. (2004) Uterine Effects of Estrogen Plus Progestin Therapy and Raloxifene: Adjudicated Results From the EURALOX Study. Obstetrics & Gynecology 103:5, Part 1, pages 881-891.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.